Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Methylprednisolone injection versus piroxicam + lidocaine mesotherapy for carpal tunnel syndrome
IRCT20261017071460N1Phase 3Recruiting
- Sponsor
- Shiraz University of Medical Sciences
- Start
- Oct 2026
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial of methylprednisolone, piroxicam and lidocaine in carpal tunnel syndrome (CTS) (2 arms), sponsored by Shiraz University of Medical Sciences. Primary endpoints: Visual Analog Scale for pain, Boston Carpal Tunnel Questionnaire and 2 more. Started Oct 2026; status: recruiting.
02
Drugs
methylprednisolonepiroxicamlidocaine
03
Conditions
carpal tunnel syndrome (CTS)
Beyond the preview
Go deeper on IRCT20261017071460N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20261017071460N1.